These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23846297)

  • 1. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
    Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
    Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells.
    Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
    Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.
    Chen PH; Yang CR
    J Immunol; 2008 Dec; 181(12):8441-9. PubMed ID: 19050262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of decoy receptor 3 enhances TRAIL-mediated apoptosis in pancreatic cancer.
    Wang W; Zhang M; Sun W; Yang S; Su Y; Zhang H; Liu C; Li X; Lin L; Kim S; Okunieff P; Zhang Z; Zhang L
    PLoS One; 2013; 8(10):e74272. PubMed ID: 24204567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
    Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
    Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.
    Tsuji S; Hosotani R; Yonehara S; Masui T; Tulachan SS; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Ito D; Kami K; Mori T; Fujimoto K; Doi R; Imamura M
    Int J Cancer; 2003 Aug; 106(1):17-25. PubMed ID: 12794752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
    Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
    Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
    Connor JP; Felder M
    Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
    Sung HY; Wu HG; Ahn JH; Park WY
    Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo.
    Li C; Chen D; Luo M; Ge M; Zhu J
    Biotechnol J; 2014 May; 9(5):652-63. PubMed ID: 24799381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2.
    Zhou XN; Li GM; Xu YC; Zhao TJ; Wu JX
    Chin Med J (Engl); 2016 Nov; 129(21):2623-2629. PubMed ID: 27779171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.
    Toda M; Kawamoto T; Ueha T; Kishimoto K; Hara H; Fukase N; Onishi Y; Harada R; Minoda M; Kurosaka M; Akisue T
    Int J Oncol; 2013 Sep; 43(3):703-12. PubMed ID: 23817777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL.
    Li W; Zhang C; Chen C; Zhuang G
    Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression.
    Wang W; Li X; Sun W; Zhang L; Zhang M; Hong B; Lv G
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1597-605. PubMed ID: 22581262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DcR3 regulates the growth and metastatic potential of SW480 colon cancer cells.
    Yu W; Xu YC; Tao Y; He P; Li Y; Wu T; Zhu YP; Li J; Wu JX; Dai J
    Oncol Rep; 2013 Dec; 30(6):2741-8. PubMed ID: 24101127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
    Im J; Kim K; Hergert P; Nho RS
    J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1.
    Xu YC; Cui J; Zhang LJ; Zhang DX; Xing BC; Huang XW; Wu JX; Liang CJ; Li GM
    Chin Med J (Engl); 2018 Jan; 131(1):82-87. PubMed ID: 29271385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.